<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860548</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.91</article-id><article-id pub-id-type="other">SP0044</article-id><article-id pub-id-type="pii">S0924933824000919</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Symposium</subject></subj-group></article-categories><title-group><article-title>Sex differences in addiction: gonadal hormones and substance use effects in women</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Fonseca</surname><given-names>F.</given-names></name><xref rid="aff3921" ref-type="aff">
<sup>1</sup></xref><xref rid="aff3922" ref-type="aff">
<sup>2</sup></xref><xref rid="aff3923" ref-type="aff">
<sup>3</sup></xref><xref rid="cor1688" ref-type="corresp">
<sup>*</sup></xref></contrib></contrib-group><aff id="aff3921">
<sup>1</sup>Addiction Section, <institution>Hospital del Mar</institution></aff><aff id="aff3922">
<sup>2</sup>Addiction Research Group, <institution>Hospital del Mar Research Institute</institution>
</aff><aff id="aff3923">
<sup>3</sup>Medicine and Life Sciences, <institution>Universitat Pompeu Fabra</institution>, <city>Barcelona</city>, <country>Spain</country>
</aff><author-notes><corresp id="cor1688">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="66">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S23</fpage><lpage>S23</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824000919a.pdf"/><abstract><sec id="sec9826"><title>Abstract</title><p>
Substance use disorders (SUD) affect differentially women and men. Although the prevalence has been reported higher in men, those women with addictive disorders present a more vulnerable profile and are less likely to enter treatment than men. The aim of this presentation is to present an overview of how gonadal hormones may influence in response to substances, clinical differences in the addictive disorders and implications in treatment response.Ovarian steroid hormones (estrogen, progesterone), the metabolites of progesterone, and negative allosteric modulators of the gamma-aminobutyric acid A (GABA-A) receptor, such as&#x000a0;dehydroepiandrostenedione (DHEA) may influence the behavioral effects of drugs.</p></sec><sec id="sec9827"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>